IL-21 conditions antigen-presenting human γδ T-cells to promote IL-10 expression in naïve and memory CD4(+) T-cells

Abstract

Direct interaction between T-cells exerts a major influence on tissue immunity and inflammation across multiple body sites including the human gut, which is highly enriched in 'unconventional' lymphocytes such as ?d T-cells. We previously reported that microbial activation of human V?9/Vd2(+) ?d T-cells in the presence of the mucosal damage-associated cytokine IL-15 confers the ability to promote epithelial barrier defence, specifically via induction of IL-22 expression in conventional CD4(+) T-cells. In the current report, we assessed whether other cytokines enriched in the gut milieu also functionally influence microbe-responsive V?9/Vd2 T-cells. When cultured in the presence of IL-21, V?9/Vd2 T-cells acquired the ability to induce expression of the immunoregulatory cytokine IL-10 in both naïve and memory CD4(+) T-cells, at levels surpassing those induced by monocytes or monocyte-derived DCs. These findings identify an unexpected influence of IL-21 on V?9/Vd2 T-cell modulation of CD4(+) T-cell responses. Further analyses suggested a possible role for CD30L and/or CD40L reverse signalling in mediating IL-10 induction by IL-21 conditioned V?9/Vd2 T-cells. Our findings indicate that the local microenvironment exerts a profound influence on V?9/Vd2 T-cell responses to microbial challenge, leading to induction of distinct functional profiles among CD4(+) T-cells that may influence inflammatory events at mucosal surfaces. Targeting these novel pathways may offer therapeutic benefit in disorders such as inflammatory bowel disease.